Fulgent Genetics Stock Analysis

Fulgent Stock Analysis Notes

About 33.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.46. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fulgent Genetics has Price/Earnings To Growth (PEG) ratio of 1.32. The entity recorded a loss per share of 1.41. The firm had not issued any dividends in recent years. Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. Fulgent Genetics operates under Diagnostics Research classification in the United States and is traded on NASDAQ Exchange. It employs 645 people. To learn more about Fulgent Genetics call Ming Hsieh at 626 350 0537 or check out https://www.fulgentgenetics.com.

Fulgent Genetics Investment Alerts

Fulgent Genetics Upcoming and Recent Events

Fulgent Largest EPS Surprises

View All Earnings Estimates

Fulgent Genetics Environmental, Social, and Governance (ESG) Scores

Fulgent Genetics Thematic Classifications

Fulgent Stock Institutional Investors

Note, although Fulgent Genetics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Fulgent Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 526.88 M.

Fulgent Profitablity

The company has Profit Margin (PM) of (0.15) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.21) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.21.

Management Efficiency

Fulgent Genetics has return on total asset (ROA) of (0.0376) % which means that it has lost $0.0376 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0387) %, meaning that it created substantial loss on money invested by shareholders. Fulgent Genetics' management efficiency ratios could be used to measure how well Fulgent Genetics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.04 in 2025. Return On Capital Employed is likely to drop to -0.07 in 2025. At this time, Fulgent Genetics' Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Other is likely to gain to about 6.7 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 52.2 M in 2025.

Technical Drivers

As of the 23rd of March, Fulgent Genetics shows the Mean Deviation of 1.88, standard deviation of 2.62, and Variance of 6.86. Fulgent Genetics technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Fulgent Genetics Price Movement Analysis

Fulgent Genetics Insider Trading Activities

Fulgent Genetics Outstanding Bonds

Fulgent Genetics Predictive Daily Indicators

Fulgent Genetics Corporate Filings

Fulgent Genetics Forecast Models

Fulgent Genetics' time-series forecasting models are one of many Fulgent Genetics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Fulgent Genetics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Fulgent Genetics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Fulgent shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Fulgent Genetics. By using and applying Fulgent Stock analysis, traders can create a robust methodology for identifying Fulgent entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Fulgent analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Fulgent analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Fulgent Genetics stock analysis indicators help investors evaluate how Fulgent Genetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Fulgent Genetics shares will generate the highest return on investment. By understating and applying Fulgent Genetics stock analysis, traders can identify Fulgent Genetics position entry and exit signals to maximize returns.

When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.